Clinical Trial Update: Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of YH14659 in healthy male subjects, presenting comparative PK data for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• YH14659

Snippet

Sponsor: Yuhan Corporation | Conditions: Acute Coronary Syndrome | Phase 1 | Status: COMPLETED